Robert Lorne Hopfner - Net Worth and Insider Trading
Robert Lorne Hopfner Net Worth
The estimated net worth of Robert Lorne Hopfner is at least $139 Million dollars as of 2024-12-01. Robert Lorne Hopfner is the Director of Vaxcyte Inc and owns about 1,405,418 shares of Vaxcyte Inc (PCVX) stock worth over $133 Million. Robert Lorne Hopfner is the Director of Inozyme Pharma Inc and owns about 1,571,741 shares of Inozyme Pharma Inc (INZY) stock worth over $4 Million. Robert Lorne Hopfner is also the Director of Rallybio Corp and owns about 2,267,411 shares of Rallybio Corp (RLYB) stock worth over $3 Million. Details can be seen in Robert Lorne Hopfner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Lorne Hopfner has not made any transactions after 2023-08-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Lorne Hopfner
Robert Lorne Hopfner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Lorne Hopfner owns 3 companies in total, including Inozyme Pharma Inc (INZY) , Vaxcyte Inc (PCVX) , and Rallybio Corp (RLYB) .
Click here to see the complete history of Robert Lorne Hopfner’s form 4 insider trades.
Insider Ownership Summary of Robert Lorne Hopfner
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2023-08-01 | director & 10 percent owner |
| PCVX | Vaxcyte Inc | 2021-02-10 | director |
| RLYB | Rallybio Corp | 2021-08-02 | director |
Robert Lorne Hopfner Latest Holdings Summary
Robert Lorne Hopfner currently owns a total of 3 stocks. Among these stocks, Robert Lorne Hopfner owns 1,405,418 shares of Vaxcyte Inc (PCVX) as of February 10, 2021, with a value of $133 Million and a weighting of 95.04%. Robert Lorne Hopfner owns 1,571,741 shares of Inozyme Pharma Inc (INZY) as of August 1, 2023, with a value of $4 Million and a weighting of 3.05%. Robert Lorne Hopfner also owns 2,267,411 shares of Rallybio Corp (RLYB) as of August 2, 2021, with a value of $3 Million and a weighting of 1.9%.
Latest Holdings of Robert Lorne Hopfner
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCVX | Vaxcyte Inc | 2021-02-10 | 1,405,418 | 94.34 | 132,587,134 |
| INZY | Inozyme Pharma Inc | 2023-08-01 | 1,571,741 | 2.71 | 4,259,418 |
| RLYB | Rallybio Corp | 2021-08-02 | 2,267,411 | 1.17 | 2,652,871 |
Holding Weightings of Robert Lorne Hopfner
Robert Lorne Hopfner Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Lorne Hopfner has made a total of 9 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in Vaxcyte Inc is the sale of 378,698 shares on February 10, 2021, which brought Robert Lorne Hopfner around $10 Million.
According to the SEC Form 4 filings, Robert Lorne Hopfner has made a total of 6 transactions in Inozyme Pharma Inc (INZY) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Inozyme Pharma Inc is the acquisition of 833,333 shares on August 1, 2023, which cost Robert Lorne Hopfner around $4 Million.
According to the SEC Form 4 filings, Robert Lorne Hopfner has made a total of 1 transactions in Rallybio Corp (RLYB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rallybio Corp is the acquisition of 576,923 shares on August 2, 2021, which cost Robert Lorne Hopfner around $8 Million.
Insider Trading History of Robert Lorne Hopfner
- 1
Robert Lorne Hopfner Trading Performance
GuruFocus tracks the stock performance after each of Robert Lorne Hopfner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Lorne Hopfner is 11.11%. GuruFocus also compares Robert Lorne Hopfner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Lorne Hopfner within 3 months outperforms 6 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Lorne Hopfner's insider trading performs compared to the benchmark.
Performance of Robert Lorne Hopfner
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.51 | | | | | |
| Relative Return to S&P 500(%) | 3.62 | | | | | |
Robert Lorne Hopfner Ownership Network
Robert Lorne Hopfner Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Robert Lorne Hopfner is the director & 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include COO Matthew Winton , See Remarks Henric Bjorn Bjarke , and director & 10 percent owner & See Remarks Axel Bolte .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Robert Lorne Hopfner made 1 insider transaction in Inozyme Pharma Inc (INZY) with a net purchase of 833,333. Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , a net sale of 7,523 shares made by Douglas A Treco ,
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Robert Lorne Hopfner Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Lorne Hopfner. You might contact Robert Lorne Hopfner via mailing address: C/o Bay City Capital, Llc, 750 Battery Street, Suite 400, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
